Publication | Closed Access

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Ide AnaloguesViral HepatitisMedicineImmunologyAntiviral Drug DevelopmentHepatitisVirologyModulator Jnj-56136379Sirna Jnj-73763989Antiviral TherapyAntiviral DrugPharmacologyAntiviral Compound